5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.21▼ | 8.19▼ | 8.20▼ | 8.25▼ | 8.08▲ |
MA10 | 8.21▼ | 8.18▼ | 8.17▲ | 8.28▼ | 7.61▲ |
MA20 | 8.19▼ | 8.14▲ | 8.31▼ | 8.06▲ | 7.74▲ |
MA50 | 8.17▼ | 8.30▼ | 8.27▼ | 7.50▲ | 10.28▼ |
MA100 | 8.13▲ | 8.32▼ | 8.28▼ | 7.75▲ | 16.19▼ |
MA200 | 8.37▼ | 8.22▼ | 7.73▲ | 9.00▼ | 21.34▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.017▲ | -0.005▼ | -0.014▼ | 0.353▲ |
RSI | 46.723▼ | 47.425▼ | 46.765▼ | 53.295▲ | 46.047▼ |
STOCH | 62.836 | 76.997 | 72.849 | 32.656 | 50.628 |
WILL %R | -68.966 | -40.000 | -63.492 | -64.498 | -42.049 |
CCI | -20.833 | 85.984 | 54.162 | -45.017 | 57.964 |
Wednesday, October 15, 2025 05:36 AM
Bicycle Therapeutics' strong cash position and planned workforce reduction extend the operational runway into 2028. See why BCYC stock is a Buy.
|
Monday, September 08, 2025 04:55 PM
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bicycle Therapeutics ( (BCYC)) has ...
|
Sunday, September 07, 2025 05:30 PM
Bicycle Therapeutics plc (NASDAQ:BCYC) is one of the Top 10 Stocks Under $10 That Could Triple. On August 11, RBC Capital increased its price target on Bicycle Therapeutics plc (NASDAQ:BCYC) from $25 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
20/10/25 | 8.17 | 8.39 | 8.02 | 8.16 | 186,204 |
17/10/25 | 8.63 | 8.73 | 7.945 | 8.17 | 256,632 |
16/10/25 | 8.53 | 8.95 | 8.48 | 8.65 | 427,940 |
15/10/25 | 7.90 | 8.50 | 7.90 | 8.39 | 311,477 |
14/10/25 | 8.02 | 8.24 | 7.87 | 7.90 | 221,828 |
13/10/25 | 8.39 | 8.41 | 8.00 | 8.12 | 192,688 |
10/10/25 | 8.97 | 9.0998 | 8.30 | 8.32 | 298,315 |
09/10/25 | 8.30 | 9.1592 | 8.30 | 8.87 | 339,284 |
08/10/25 | 8.10 | 8.426 | 8.01 | 8.26 | 589,258 |
07/10/25 | 8.19 | 8.20 | 7.80 | 8.00 | 272,903 |
|
|
||||
|
|
||||
|
|